These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 21706132)
1. Cancer stroma proteome expression profile of superficial bladder transitional cell carcinoma and biomarker discovery. Niu HT; Yang CM; Jiang G; Xu T; Cao YW; Zhao J; Wang XS J Cancer Res Clin Oncol; 2011 Aug; 137(8):1273-82. PubMed ID: 21706132 [TBL] [Abstract][Full Text] [Related]
2. Stromal proteome expression profile and muscle-invasive bladder cancer research. Niu H; Jiang H; Cheng B; Li X; Dong Q; Shao L; Liu S; Wang X Cancer Cell Int; 2012 Aug; 12(1):39. PubMed ID: 22920603 [TBL] [Abstract][Full Text] [Related]
3. Far from resolved: stromal cell-based iTRAQ research of muscle-invasive bladder cancer regarding heterogeneity. Liu PF; Wang YH; Cao YW; Jiang HP; Yang XC; Wang XS; Niu HT Oncol Rep; 2014 Oct; 32(4):1489-96. PubMed ID: 25050759 [TBL] [Abstract][Full Text] [Related]
4. Differences in shotgun protein expression profile between superficial bladder transitional cell carcinoma and normal urothelium. Niu HT; Zhang YB; Jiang HP; Cheng B; Sun G; Wang Y; E YJ; Pang de Q; Chang JW Urol Oncol; 2009; 27(4):400-6. PubMed ID: 18818109 [TBL] [Abstract][Full Text] [Related]
5. Biomarker research and some deduction in superficial bladder cancer cells combined with corresponding stroma. Niu HT; Yang CM; Chen B; Dong Q Cancer Biomark; 2011-2012; 10(2):109-16. PubMed ID: 22430138 [TBL] [Abstract][Full Text] [Related]
6. Proteomics research on muscle-invasive bladder transitional cell carcinoma. Niu HT; Dong Z; Jiang G; Xu T; Liu YQ; Cao YW; Zhao J; Wang XS Cancer Cell Int; 2011 Jun; 11(1):17. PubMed ID: 21645413 [TBL] [Abstract][Full Text] [Related]
7. Shotgun proteome expression profile of microdissected superficial transitional cell carcinoma and biomarker discovery from urine. Niu HT; Li SJ; Xu T; Yu QC; Chang JW; Sun G Mol Med Rep; 2009; 2(5):719-23. PubMed ID: 21475891 [TBL] [Abstract][Full Text] [Related]
8. Parallel proteomic analysis in muscle-invasive bladder transitional cell carcinoma and cancer-related stroma. Niu HT; Qi XJ; Liu YQ; Cao YW; Dong Q; Wang XS Genet Mol Res; 2013 Feb; 12(4):4251-63. PubMed ID: 23479173 [TBL] [Abstract][Full Text] [Related]
9. Heterogeneity research in muscle-invasive bladder cancer based on differential protein expression analysis. Liu PF; Cao YW; Jiang HP; Wang YH; Yang XC; Wang XS; Niu HT Med Oncol; 2014 Sep; 31(9):21. PubMed ID: 25085780 [TBL] [Abstract][Full Text] [Related]
10. Differential proteomic analysis of nuclear matrix in muscle-invasive bladder cancer: potential to improve diagnosis and prognosis. Barboro P; Rubagotti A; Orecchia P; Spina B; Truini M; Repaci E; Carmignani G; Romagnoli A; Introini C; Boccardo F; Carnemolla B; Balbi C Cell Oncol; 2008; 30(1):13-26. PubMed ID: 18219107 [TBL] [Abstract][Full Text] [Related]
11. In situ proteomic analysis of human breast cancer epithelial cells using laser capture microdissection: annotation by protein set enrichment analysis and gene ontology. Cha S; Imielinski MB; Rejtar T; Richardson EA; Thakur D; Sgroi DC; Karger BL Mol Cell Proteomics; 2010 Nov; 9(11):2529-44. PubMed ID: 20739354 [TBL] [Abstract][Full Text] [Related]
12. Nuclear overexpression of p53 protein in transitional cell bladder carcinoma: a marker for disease progression. Sarkis AS; Dalbagni G; Cordon-Cardo C; Zhang ZF; Sheinfeld J; Fair WR; Herr HW; Reuter VE J Natl Cancer Inst; 1993 Jan; 85(1):53-9. PubMed ID: 7677935 [TBL] [Abstract][Full Text] [Related]
13. Cytokeratin 20: a new marker for early detection of bladder cell carcinoma? Buchumensky V; Klein A; Zemer R; Kessler OJ; Zimlichman S; Nissenkorn I J Urol; 1998 Dec; 160(6 Pt 1):1971-4. PubMed ID: 9817302 [TBL] [Abstract][Full Text] [Related]
15. Biological characterisation of superficial bladder cancer by bivariate cytokeratin 7/DNA analysis, flow cytometric assessment of MIB- 1, and an immunohistochemical study. Leonardi E; Dalla Palma P; Reich A; Caffo O; Luciani L Anal Cell Pathol; 2000; 21(1):21-33. PubMed ID: 11254222 [TBL] [Abstract][Full Text] [Related]
16. Urinary protein profiling by liquid chromatography/tandem mass spectrometry: ADAM28 is overexpressed in bladder transitional cell carcinoma. Tyan YC; Yang MH; Chen SC; Jong SB; Chen WC; Yang YH; Chung TW; Liao PC Rapid Commun Mass Spectrom; 2011 Oct; 25(19):2851-62. PubMed ID: 21913264 [TBL] [Abstract][Full Text] [Related]
17. Motility- and adhesion factors in bladder carcinoma. Otto T; Goepel M; Enzwi SM; Meyer-Schwickerath M; Rübben H Investig Urol (Berl); 1994; 5():80-4. PubMed ID: 7719326 [No Abstract] [Full Text] [Related]
18. Identifying superficial, muscle-invasive, and metastasizing transitional cell carcinoma of the bladder: use of cDNA array analysis of gene expression profiles. Modlich O; Prisack HB; Pitschke G; Ramp U; Ackermann R; Bojar H; Vögeli TA; Grimm MO Clin Cancer Res; 2004 May; 10(10):3410-21. PubMed ID: 15161696 [TBL] [Abstract][Full Text] [Related]
19. Expression of pS2 protein in transitional cell bladder tumours. Lipponen PK; Eskelinen MJ J Pathol; 1994 Aug; 173(4):327-32. PubMed ID: 7965392 [TBL] [Abstract][Full Text] [Related]
20. Stromal and vascular invasion in an human in vitro bladder cancer model. Booth C; Harnden P; Trejdosiewicz LK; Scriven S; Selby PJ; Southgate J Lab Invest; 1997 Jun; 76(6):843-57. PubMed ID: 9194860 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]